NAMPT and pulmonary fibrosis: These results suggested that both NAMPT cKO in monocytes/macrophages and NAMPT inhibitor FK866 mitigated BLM-induced lung fibrosis injury in mice, at least partly through inhibiting macrophages M2 programming.